-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
ML303
Category | Influenza Virus |
CAS | 1638211-04-7 |
Description | ML303 is an antagonist of pyrazolopyridine influenza virus nonstructural protein 1 (NS1). |
Product Information
Synonyms | ML-303; ML 303 |
IUPAC Name | 2-methoxy-4-[3-methyl-1-[4-(trifluoromethyl)phenyl]pyrazolo[3,4-b]pyridin-4-yl]phenol |
Molecular Weight | 399.4 |
Molecular Formula | C21H16F3N3O2 |
Canonical SMILES | CC1=NN(C2=NC=CC(=C12)C3=CC(=C(C=C3)O)OC)C4=CC=C(C=C4)C(F)(F)F |
InChI | InChI=1S/C21H16F3N3O2/c1-12-19-16(13-3-8-17(28)18(11-13)29-2)9-10-25-20(19)27(26-12)15-6-4-14(5-7-15)21(22,23)24/h3-11,28H,1-2H3 |
InChIKey | YBRHGNCGFMRGSV-UHFFFAOYSA-N |
Purity | 98% by HPLC |
Solubility | In vitro: 10 mM in DMSO |
Appearance | White to Off-white Solid |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 556 |
Exact Mass | 399.11946125 |
In Vitro | ML303 (20 μM, 6 h) treatment restore IFN-β mRNA levels in MDCK cells. Western Blot Analysis Cell Line: MDCK cells infected with A/PR/8/34, at a MOI of 2, for 6 hours Concentration: 20 μM Incubation Time: 6 hours Result: Restored IFN-β mRNA levels in MDCK cells |
In Vivo | ML303 (20 μM, 6 h) treatment restore IFN-β mRNA levels in MDCK cells. |
Target | Influenza Virus |
XLogP3-AA | 5 |